Seitaro Terakura

35PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|May 13, 2026
Impact of Glycine-Serine Linker on Target Antigen Binding and Subsequent CD37CAR-T Performance.

|Apr 13, 2026
BATF3 regulates differentiation of CD8+ T lymphocytes and memory differentiation program.

Koji Umemura, Yasuhiro Kojima, Jakrawadee Julamanee

|Mar 11, 2026
CD79A/CD40 intracellular domain uses a 4-1BB-like metabolic pathway driven by cholesterol biosynthesis.

Yuki Takeuchi, Seitaro Terakura, Kohei Ishigiwa

|May 25, 2025
Robust CAR T-cell expansion and superior outcomes in DLBCL patients in complete response at infusion.

Ryo Hanajiri, Hiroya Wakabayashi, Kohei Ishigiwa

|May 09, 2025
Development and optimization of Eva1 (MPZL2) targeting chimeric antigen receptor T cells.

Masahide Osaki, Seitaro Terakura, Shiho Hirano

|Dec 10, 2024
Cullin-5 deficiency promotes chimeric antigen receptor T cell effector functions potentially via the modulation of JAK/STAT signaling pathway.

Yoshitaka Adachi, Seitaro Terakura, Masahide Osaki

Pageof 6

Frequent Collaborators

9 joint publications

Yoshiko Atsuta

7 joint publications

Junya Kanda

6 joint publications

Makoto Murata

4 joint publications

Hitoshi Kiyoi